C2402
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for C2402, covering 2025-09-09 to 2025-09-09. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia [Phase 3]